Skip to main content

Market Overview

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Share:

 

Gainers

  • Kindred Biosciences (NASDAQ:KIN) shares moved upwards by 45.26% to $9.21 during Wednesday's pre-market session. The market value of their outstanding shares is at $416.9 million.
  • Catabasis Pharmaceuticals (NASDAQ:CATB) stock increased by 16.17% to $2.37. The market value of their outstanding shares is at $182.3 million.
  • MannKind (NASDAQ:MNKD) shares increased by 10.0% to $4.51. The company's market cap stands at $1.1 billion.
  • Aprea Therapeutics (NASDAQ:APRE) shares moved upwards by 9.48% to $5.31. The company's market cap stands at $112.5 million.
  • Macrogenics (NASDAQ:MGNX) shares rose 7.36% to $22.0. The company's market cap stands at $1.3 billion.
  • Vera Therapeutics (NASDAQ:VERA) stock increased by 6.87% to $17.1.

 

 

Losers

 

  • Clearside Biomedical (NASDAQ:CLSD) stock fell 10.58% to $3.72 during Wednesday's pre-market session. The company's market cap stands at $214.1 million.
  • GBS (NASDAQ:GBS) shares decreased by 5.97% to $4.1.
  • Fusion Pharmaceuticals (NASDAQ:FUSN) stock declined by 5.92% to $9.07. The market value of their outstanding shares is at $385.0 million.
  • RAPT Therapeutics (NASDAQ:RAPT) shares decreased by 5.09% to $33.4. The market value of their outstanding shares is at $835.3 million.
  • Novavax (NASDAQ:NVAX) shares decreased by 4.69% to $178.3. The market value of their outstanding shares is at $13.2 billion.
  • OpGen (NASDAQ:OPGN) stock fell 4.65% to $2.26. The company's market cap stands at $86.4 million.

 

 

 

Related Articles (KIN + CATB)

View Comments and Join the Discussion!

Posted-In: BZI-TFMPre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com